Organon (OGN) Change in Receivables (2020 - 2026)

Organon (OGN) has reported Change in Receivables for 7 consecutive years, with $65.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Receivables fell 23.53% year-over-year to $65.0 million; the TTM figure through Mar 2026 stood at -$99.0 million (up 26.67% YoY), while the FY2025 annual figure was -$79.0 million, up 79.37% from the prior year.
• Change in Receivables came in at $65.0 million for Q1 2026 at Organon, up from -$160.0 million in the prior quarter.
• The five-year high for Change in Receivables was $230.0 million in Q2 2023, with the low at -$341.0 million in Q4 2024.
• Average Change in Receivables over 5 years is -$3.6 million, with a median of $4.0 million recorded in 2022.
• The largest YoY upside for Change in Receivables was 866.67% in 2024 against a maximum downside of 1362.96% in 2024.
• Year by year, Change in Receivables stood at $4.0 million in 2022, then surged by 575.0% to $27.0 million in 2023, then slumped by 1362.96% to -$341.0 million in 2024, then surged by 53.08% to -$160.0 million in 2025, then surged by 140.62% to $65.0 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $65.0 million, -$160.0 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.